Traded Mar 18 · filed 1 day later
Derivative exercise or conversion — not an open-market buy.
Traded Feb 17, 2026 · Filed Feb 18, 2026
TransDigm's Co-Chief Operating Officer sold $423K of TransDigm shares. The filing does not indicate a pre-arranged trading plan.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
open market sale
Code S — open-market or private sale
~$422,982
Shares × reported transaction price
14 days after results of Feb 3, 2026, 56 days before results of Apr 14, 2026
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
Closed at $1,302.11 on Feb 17, 2026, 6% above its 52-week low and 20% below its high, after a 4% drop over the previous 30 trading days
52-week range $1,231.75 (Apr 8, 2025) to $1,620.83 (Jul 30, 2025), 18% of the way up, from 251 adjusted closes. 30 trading days earlier: $1,358.55 on Jan 2, 2026. Describes the past only, not a forecast
None found in footnotes
Only flagged when a footnote says so; never inferred
| After | Stock | S&P 500 | Difference |
|---|---|---|---|
| 7 days | −1.2% | +0.7% | −1.9% |
| 30 days | −13.3% | −4.3% | −9.1% |
| 90 days | −9.9% | +8.3% | −18.2% |
| 180 days | −7.2% | +12.1% | −19.4% |
Past results only. Not a forecast.
Traded Mar 18 · filed 1 day later
Derivative exercise or conversion — not an open-market buy.
Traded Mar 18 · filed 1 day laterNot under a reported trading plan
A TransDigm director sold $243K of TransDigm shares. The filing does not indicate a pre-arranged trading plan.
Traded Mar 18 · filed 1 day laterNot under a reported trading plan
A TransDigm director sold $611K of TransDigm shares. The filing does not indicate a pre-arranged trading plan.